GSK Investigational Site

Costa Mesa, California 92626

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 1, Fabry Disease, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic, Perennial

Studies at this site

• Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma — Completed
• A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
• Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function — Completed
• A Dose-ranging Study of Fluticasone Furoate (FF) — Completed
• Perennial Allergic Rhinitis Study In Pediatric Subjects — Completed
• Seasonal Allergic Rhinitis In Pediatric Subjects — Completed